viruses Article Gut Microbiome Changes Associated with Epithelial Barrier Damage and Systemic Inflammation during Antiretroviral Therapy of Chronic SIV Infection Ceylan Tanes 1, Edith M. Walker 2, Nadia Slisarenko 2, Giovanni L. Gerrets 2, Brooke F. Grasperge 3, Xuebin Qin 4, S. Michal Jazwinski 5, Frederic D. Bushman 6, Kyle Bittinger 1 and Namita Rout 2,5,* 1 Division of Gastroenterology, Hepatology and Nutrition, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA;
[email protected] (C.T.);
[email protected] (K.B.) 2 Division of Microbiology, Tulane National Primate Research Center, Tulane University, Covington, LA 70433, USA;
[email protected] (E.M.W.);
[email protected] (N.S.);
[email protected] (G.L.G.) 3 Division of Veterinary Medicine, Tulane National Primate Research Center, Tulane University, Covington, LA 70433, USA;
[email protected] 4 Division of Comparative Pathology, Tulane National Primate Research Center, Tulane University, Covington, LA 70433, USA;
[email protected] 5 Tulane Center for Aging, Tulane University School of Medicine, New Orleans, LA 70112, USA;
[email protected] 6 Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA;
[email protected] Citation: Tanes, C.; Walker, E.M.; * Correspondence:
[email protected] Slisarenko, N.; Gerrets, G.L.; Grasperge, B.F.; Qin, X.; Jazwinski, Abstract: Gut dysbiosis is a common feature associated with the chronic inflammation of HIV infec- S.M.; Bushman, F.D.; Bittinger, K.; Rout, N. Gut Microbiome Changes tion. Toward understanding the interplay of chronic treated HIV infection, dysbiosis, and systemic Associated with Epithelial Barrier inflammation, we investigated longitudinal fecal microbiome changes and plasma inflammatory Damage and Systemic Inflammation markers in the nonhuman primate model.